Novo Nordisk

novonordisk.com · Denmark

Novo Nordisk is a global healthcare company that researches, develops, manufactures, and markets pharmaceutical products, with a primary focus on diabetes care, obesity treatments, and other serious chronic diseases such as rare blood and endocrine disorders. It sells prescription medicines and related therapies to healthcare systems, hospitals, and pharmacies worldwide through a mix of direct sales and distribution partners. The company generates revenue from patented drugs, biologics, and associated delivery devices across more than 170 countries.

Revenue
$1B+
Employees
5,001+
Founded
1923
Headquarters
Denmark

Novo Nordisk customers on Arbolus

Total customers 11 11 current · 0 former
Reviews growth 4 new reviews since Apr 2026

Customers who reviewed Novo Nordisk

Seniority of Novo Nordisk customers

Most people who reviewed Novo Nordisk hold C-Suite roles (64%), followed by Director (27%) and Manager (9%).

  • C-Suite 64%
  • Director 27%
  • Manager 9%

Customers sample

Not specified Director NPS 9
Operations Leader C-Suite NPS 9 Will renew
Operations Ops C-Suite NPS 10 Undecided

Employer names and spend open once the report publishes.

What 10 Arbolus experts think of Novo Nordisk

Overall sentiment: Positive

NPS scores in the provided insights range from 3 to 10, with the majority clustering at 8-9. High renewal intent aligns with those giving top NPS scores, particularly among Influencers at high spend levels. Most Users remain in mature implementation stages, demonstrating stickiness, while newer or pilot-stage Users report moderately positive sentiment. Key themes include established effectiveness and vendor reliability.

Tell us when the Novo Nordisk report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Sentiment

30 Net Promoter Score, from 10 scored reviews
  • Promoters 4
  • Passives 5
  • Detractors 1

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 33%
  • Will renew 1
  • Undecided 2
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 50% 2 answers
  • Manager 0% 1 answer
  • 9/10 Average score from customers who will renew
  • 9/10 Average score from undecided customers

For people who use Novo Nordisk

Do you use Novo Nordisk at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 10 customers of Novo Nordisk have already contributed

Takes a few minutes. Your identity stays anonymous.